Nav: Home

Scientists take aging cardiac stem cells out of semiretirement to improve stem cell therapy

October 03, 2016

AUGUSTA, Ga. (Oct. 3, 2016) - With age, the chromosomes of our cardiac stem cells compress as they move into a state of safe, semiretirement.

The typically long, coiled strand of DNA inside each youthful stem cell gets shorter and dense as we age, literally leaving less room for it to be cut or otherwise damaged and die, said Dr. Yaoliang Tang, cardiovascular researcher in the Vascular Biology Center at the Medical College of Georgia at Augusta University.

"If you condense it, it's less responsive," Tang said. "The cells look like they fall asleep," he said of a scenario that plays out in aging stem cells all over the body. But that protective, condensing strategy also means a preconditioning treatment that will help stem cells make new blood vessels for starving heart muscle doesn't have good access either.

Tang is principal investigator on a new $1.5 million grant from the National Heart, Lung and Blood Institute that is enabling him to restore the youthful length to the DNA just long enough to his get preconditioning therapy inside. Then, his research team will see what that does to the stem cell's ability to revascularize heart muscle following a heart attack, improve heart function and possibly help avoid worsening disease.

"When the chromosome is open, it will make the cells wake up," Tang said. His early evidence suggests that the rejuvenated stem cells will respond better to a short period of hypoxia - or reduced oxygen levels - that encourages them to make things that are good for the ailing heart. This includes vascular endothelial growth factor, or VEGF, that will pave the inside of new blood vessels; endothelial nitric oxide synthase, or eNOS, that will help blood vessels dilate; and placental growth factor that is highly expressed in the embryo and will also aid development of new blood vessels, called angiogenesis.

With age, the number of cardiac stem cells - which can form a myriad of heart tissue from actual heart cells to the blood vessels that feed them - decreases. Inside those that remain, expression of the enzyme EZH2 goes way up, which appears to contribute to the cells' semiretirement. The drug DZnep, already used in patients to open up the DNA of cancer cells and make them more vulnerable to cancer therapy, is one way to temporarily rouse the stem cells. Tang notes this shows there is a "druggable" target so his study findings should translate well to humans. MCG researchers also are using molecules called small interfering RNAs, or siRNAs, to ablate the enzyme EZH2 and see what happens.

Tang's goals include learning more about how EZH2 is regulated and how it in turn, essentially turns down the responsiveness of aging stem cells. While his next round of studies will likely follow how many actual new heart cells are made by the temporarily rejuvenated stem cells, this time his focus is the growth of new blood vessels that will help reperfuse the ailing heart and would be essential to survival of any new heart cells.

His team will follow the mice one to two months to see what happens after cell transplantation, said Tang, noting that the response should be fairly rapid. Adding a fluorescent tag to the transplanted stem cells will enable them to see where the cells go, and sophisticated imaging technology will enable them to examine perfusion of the mice's working heart. In his early studies, Tang has already watched the aged chromosomes extend then retract when treated with DZnep. Now his team is doing studies in both younger and aged cardiac stem cells to enable continued comparison of the two populations. In fact, Tang is optimistic their approach will also enhance the efficiency of the younger cells as well.

Tang was first author on a 2009 paper in the journal Circulation Research that showed a period of hypoxia, or low-oxygen levels, prior to transplant improved the ability of transplanted cardiac stem cells to reach the ailing heart and improve heart function.

Inside the heart, stem cells are accustomed to oxygen levels that are about five times lower than the ones they will experience when taken out of the body in preparation for a transplant. His hypoxia preconditioning takes oxygen levels even lower, to embryonic levels, when stem cells were busy making entire organs. The low-oxygen environ appears to put the cells into action mode, activating the protein CXCR4, which in turn, activates signaling pathways that enable beneficial things like cell growth and division and work as a sort of homing system so the stem cells can find their way back to the heart after transplant.

Those first studies were done in a younger mouse model. But typically it's older patients who have heart attacks, and older stem cells, the researchers would find, were not as responsive to the hypoxia preconditioning, likely a reason that limited experience with cardiac stem cell transplants has not yielded the benefit to patients that laboratory studies would have indicated, Tang said.

Tang, an MD/PhD, who worked as a cardiac surgeon in China for more than a decade, says the cardiac stem cell therapy should one day be a good adjunct therapy for coronary bypass surgery patients and potential stand-alone therapy for patients with lesser ischemic heart disease or heart failure to rebuild the heart's microcirculation, perfusion and function. The technique of reopening the chromosomes of aged stem cells of all types could also improve the efficacy other types of stem cell therapies, Tang said.
-end-


Medical College of Georgia at Augusta University

Related Stem Cells Articles:

A protein that stem cells require could be a target in killing breast cancer cells
Researchers have identified a protein that must be present in order for mammary stem cells to perform their normal functions.
Approaching a decades-old goal: Making blood stem cells from patients' own cells
Researchers at Boston Children's Hospital have, for the first time, generated blood-forming stem cells in the lab using pluripotent stem cells, which can make virtually every cell type in the body.
New research finds novel method for generating airway cells from stem cells
Researchers have developed a new approach for growing and studying cells they hope one day will lead to curing lung diseases such as cystic fibrosis through 'personalized medicine.'
Mature heart muscle cells created in the laboratory from stem cells
Generating mature and viable heart muscle cells from human or other animal stem cells has proven difficult for biologists.
Mutations in bone cells can drive leukemia in neighboring stem cells
DNA mutations in bone cells that support blood development can drive leukemia formation in nearby blood stem cells.
Scientists take aging cardiac stem cells out of semiretirement to improve stem cell therapy
With age, the chromosomes of our cardiac stem cells compress as they move into a state of safe, semiretirement.
Purest yet liver-like cells generated from induced pluripotent stem cells
A team of researchers from the Medical University of South Carolina and elsewhere has found a better way to purify liver cells made from induced pluripotent stem cells.
Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood
International stem cell scientists, co-led in Canada by Dr. John Dick and in the Netherlands by Dr.
Stem cells from diabetic patients coaxed to become insulin-secreting cells
Signaling a potential new approach to treating diabetes, researchers at Washington University School of Medicine in St.

Related Stem Cells Reading:

Stem Cell Therapy: A Rising Tide: How Stem Cells Are Disrupting Medicine and Transforming Lives
by Neil H Riordan (Author)

Stem Cells: A Short Course
by Rob Burgess (Author)

Stem Cells: An Insider's Guide
by Paul Knoepfler (Author)

Stem Cell Revolution: Discover 26 Disruptive Technological Advances to Stem Cell Activation
by Joseph Christiano (Author)

Stem Cells: Promise And Reality
by Lygia V Pereira (Author)

The Science of Stem Cells
by Jonathan M. W. Slack (Author)

Essentials of Stem Cell Biology
by Robert Lanza (Editor), Anthony Atala (Editor)

The Stem Cell Revolution
by Mark Berman MD (Author), Elliot Lander MD (Contributor)

Stem Cells: A Very Short Introduction
by Jonathan Slack (Author)

Stem Cells For Dummies
by Lawrence S.B. Goldstein (Author), Meg Schneider (Author)

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Dying Well
Is there a way to talk about death candidly, without fear ... and even with humor? How can we best prepare for it with those we love? This hour, TED speakers explore the beauty of life ... and death. Guests include lawyer Jason Rosenthal, humorist Emily Levine, banker and travel blogger Michelle Knox, mortician Caitlin Doughty, and entrepreneur Lux Narayan.
Now Playing: Science for the People

#491 Frankenstein LIVES
Two hundred years ago, Mary Shelley gave us a legendary monster, shaping science fiction for good. Thanks to her, the name of Frankenstein is now famous world-wide. But who was the real monster here? The creation? Or the scientist that put him together? Tune in to a live show from Dragon Con 2018 in Atlanta, as we breakdown the science of Frankenstein, complete with grave robbing and rivers of maggots. Featuring Tina Saey, Lucas Hernandez, Travor Valle, and Nancy Miorelli. Moderated by our own Bethany Brookshire. Related links: Scientists successfully transplant lab-grown lungs into pigs, by Maria Temming on Science...